Opus Genetics Valuation
| IRD Stock | 3.64 0.25 7.37% |
At this time, the company appears to be undervalued. Opus Genetics holds a recent Real Value of USD4.54 per share. The prevailing price of the company is USD3.64. Our model determines the value of Opus Genetics from analyzing the company fundamentals such as Return On Equity of -3.39, shares owned by insiders of 14.77 %, and Current Valuation of 220.94 M as well as examining its technical indicators and probability of bankruptcy.
Undervalued
Today
Please note that Opus Genetics' price fluctuation is unstable at this time. Calculation of the real value of Opus Genetics is based on 3 months time horizon. Increasing Opus Genetics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Opus stock is determined by what a typical buyer is willing to pay for full or partial control of Opus Genetics. Since Opus Genetics is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Opus Stock. However, Opus Genetics' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 3.64 | Real 4.54 | Hype 3.47 |
The real value of Opus Stock, also known as its intrinsic value, is the underlying worth of Opus Genetics Company, which is reflected in its stock price. It is based on Opus Genetics' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Opus Genetics' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Opus Genetics helps investors to forecast how Opus stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Opus Genetics more accurately as focusing exclusively on Opus Genetics' fundamentals will not take into account other important factors: About Opus Genetics Valuation
The stock valuation mechanism determines Opus Genetics' current worth on a weekly basis. Our valuation model uses a comparative analysis of Opus Genetics. We calculate exposure to Opus Genetics's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Opus Genetics's related companies.Complementary Tools for Opus Stock analysis
When running Opus Genetics' price analysis, check to measure Opus Genetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Opus Genetics is operating at the current time. Most of Opus Genetics' value examination focuses on studying past and present price action to predict the probability of Opus Genetics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Opus Genetics' price. Additionally, you may evaluate how the addition of Opus Genetics to your portfolios can decrease your overall portfolio volatility.
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |